Please provide your email address to receive an email when new articles are posted on . The ICoN-1 trial has been discontinued, and futility was the reason for this decision. The company is still ...

(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness. For ...

The FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive pulmonary disease (COPD) in adults, drugmaker Verona Pharma announced on Wednesday. A first-in-class ...

The last time I spoke about United Therapeutics (UTHR) it was with respect to a Seeking Alpha article entitled "United Therapeutics: Ability To Expand Tyvaso To Large IPF Market". With respect to this ...

(RTTNews) - United Therapeutics Corp. (UTHR), Tuesday announced that its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for the treatment of idiopathic ...

Earwax (cerumen) protects the inside of your ears from irritation and infection. As the body makes new wax, the old earwax usually drains out of your ears naturally. Sometimes earwax can build up and ...

The power of a great scent should not be underestimated. It can lift your mood, make you feel relaxed and take you back to a core memory. I’ve burned many candles in my home but remain paranoid that I ...

With a lucrative tax credit, the Biden administration is hoping to establish a new industry that might help fight climate change. By Brad Plumer Reporting from Washington The Biden administration on ...

The first and largest of its kind: a 30 MW, pure-hydrogen electrical generator called the Jupiter One just completed its first successful full-system test. The Jupiter One is the most powerful and ...